Core Financial Statements From 2010 to 2026

CLB Stock  USD 18.42  0.21  1.13%   
Core Laboratories' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Core Laboratories' valuation are provided below:
Gross Profit
108.9 M
Profit Margin
0.0604
Market Capitalization
863.8 M
Enterprise Value Revenue
1.3706
Revenue
526.5 M
We have found one hundred twenty available fundamental signals for Core Laboratories NV, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Core Laboratories NV prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. As of February 23, 2026, Market Cap is expected to decline to about 694.1 M. In addition to that, Enterprise Value is expected to decline to about 831.7 M

Core Laboratories Total Revenue

616.62 Million

Check Core Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.5 M, Interest Expense of 10.3 M or Selling General Administrative of 35.3 M, as well as many indicators such as Price To Sales Ratio of 2.6, Dividend Yield of 0.0024 or PTB Ratio of 2.53. Core financial statements analysis is a perfect complement when working with Core Laboratories Valuation or Volatility modules.
  
Build AI portfolio with Core Stock
Check out the analysis of Core Laboratories Correlation against competitors.

Core Laboratories Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets556.9 M597 M582.9 M
Pretty Stable
Short and Long Term Debt Total219.7 M206.3 M255.5 M
Very volatile
Other Current Liabilities49.4 M58.4 M49.4 M
Pretty Stable
Total Current Liabilities101.4 M107.2 M104.8 M
Pretty Stable
Property Plant And Equipment Net123.2 M153.8 M139 M
Slightly volatile
Net Debt187.1 M183.5 M232.4 M
Very volatile
Retained Earnings193.2 M172.8 M189.5 M
Slightly volatile
Accounts Payable36.5 M37.3 M37.8 M
Pretty Stable
Cash29.8 M22.8 M18.3 M
Pretty Stable
Non Current Assets Total330.4 M374.6 M361.1 M
Slightly volatile
Cash And Short Term Investments29.8 M22.8 M18.3 M
Pretty Stable
Net Receivables129.4 M113.5 M133 M
Pretty Stable
Common Stock Shares Outstanding40.6 M46.5 M45.2 M
Pretty Stable
Liabilities And Stockholders Equity556.9 M597 M582.9 M
Pretty Stable
Non Current Liabilities Total265.8 M210 M320.6 M
Very volatile
Inventory41.2 M54.5 M45.6 M
Slightly volatile
Other Current Assets26.1 M31.5 M25.2 M
Very volatile
Total Liabilities367.2 M317.2 M425.4 M
Very volatile
Property Plant And Equipment Gross565 M538 M224.6 M
Slightly volatile
Total Current Assets226.4 M222.4 M221.7 M
Very volatile
Short Term Debt13.8 M11.5 M10.5 M
Slightly volatile
Intangible Assets231.8 M220.8 M35.1 M
Slightly volatile
Common Stock Total Equity1.1 M1.4 M1.2 M
Slightly volatile
Common Stock293.7 M279.8 M34.7 M
Slightly volatile
Other Liabilities66.4 M86.9 M80.7 M
Slightly volatile
Other Assets271.6 M258.7 M98.4 M
Slightly volatile
Long Term Debt220.2 M110.3 M227.8 M
Slightly volatile
Property Plant Equipment131 M153.8 M134.8 M
Slightly volatile
Current Deferred Revenue11.1 M10.7 M11.2 M
Slightly volatile
Good Will165.1 M220.8 M155.3 M
Pretty Stable
Warrants7.1 MM8.7 M
Slightly volatile
Non Current Liabilities Other46.6 M23.8 M41.5 M
Very volatile
Long Term Debt Total190.4 M110.3 M234.3 M
Slightly volatile
Capital Surpluse75.1 M126 M64.5 M
Slightly volatile
Deferred Long Term Asset Charges81.3 M77.4 M39.2 M
Slightly volatile
Short and Long Term Debt239.9 M204.7 M255.1 M
Slightly volatile
Long Term Investments4.2 M5.8 M3.6 M
Slightly volatile
Cash And Equivalents17.3 M22.8 M15.5 M
Slightly volatile
Net Invested Capital276 M340.3 M351.7 M
Slightly volatile
Net Working Capital122 M148.4 M110.3 M
Slightly volatile
Capital Stock773.1 K423 KM
Slightly volatile
Capital Lease Obligations48.3 M48.6 M67.5 M
Slightly volatile

Core Laboratories Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization21.5 M14.6 M20.6 M
Pretty Stable
Selling General Administrative35.3 M42.7 M41.5 M
Pretty Stable
Total Revenue616.6 M526.5 M657.2 M
Slightly volatile
Gross Profit167.7 M94.3 M178.3 M
Slightly volatile
Other Operating Expenses500.3 M477.7 M532.3 M
Pretty Stable
EBIT46.4 M48.9 M126.9 M
Slightly volatile
EBITDA60.3 M63.5 M147.1 M
Slightly volatile
Cost Of Revenue448.9 M432.2 M478.9 M
Pretty Stable
Total Operating Expenses51.4 M45.4 M53.3 M
Pretty Stable
Selling And Marketing Expenses2.2 M1.2 M1.8 M
Slightly volatile
Interest Income9.8 M10.6 M12.1 M
Slightly volatile
Reconciled Depreciation15.8 M13.5 M21.3 M
Slightly volatile
Non Recurring97.8 M110 M120 M
Slightly volatile

Core Laboratories Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow21.5 M22.6 M98.4 M
Slightly volatile
Begin Period Cash Flow29.2 M19.2 M24.7 M
Slightly volatile
Depreciation21.5 M14.6 M20.6 M
Pretty Stable
Dividends Paid1.8 M1.9 M44.2 M
Slightly volatile
Capital Expenditures16.6 M14.6 M19.5 M
Slightly volatile
Total Cash From Operating Activities35.3 M37.2 M117.7 M
Slightly volatile
End Period Cash Flow29.8 M22.8 M18.3 M
Pretty Stable
Stock Based Compensation13.4 M7.1 M16.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.61.41573.9559
Slightly volatile
Dividend Yield0.00240.00250.0132
Pretty Stable
Days Sales Outstanding90.1778.701177.3013
Slightly volatile
Free Cash Flow Yield0.02470.03030.033
Slightly volatile
Operating Cash Flow Per Share0.760.79952.634
Slightly volatile
Stock Based Compensation To Revenue0.01780.01360.0234
Very volatile
Capex To Depreciation1.170.99590.9412
Slightly volatile
EV To Sales2.841.76424.3128
Slightly volatile
Free Cash Flow Per Share0.460.48572.2047
Slightly volatile
Inventory Turnover12.367.931510.912
Slightly volatile
Days Of Inventory On Hand28.0846.018936.4839
Slightly volatile
Payables Turnover9.9311.595912.7363
Pretty Stable
Sales General And Administrative To Revenue0.05320.06630.0644
Slightly volatile
Capex To Revenue0.04520.02770.0295
Pretty Stable
Cash Per Share0.460.49130.3943
Very volatile
POCF Ratio17.4220.050424.86
Very volatile
Capex To Operating Cash Flow0.440.39240.2416
Slightly volatile
PFCF Ratio34.6533.001133.9176
Slightly volatile
Days Payables Outstanding33.2331.476729.2068
Pretty Stable
EV To Operating Cash Flow19.2824.985928.0731
Pretty Stable
EV To Free Cash Flow43.1841.124438.9791
Slightly volatile
Intangibles To Total Assets0.340.36990.2981
Pretty Stable
Net Debt To EBITDA3.032.88932.1624
Slightly volatile
Current Ratio2.652.07492.1639
Pretty Stable
Receivables Turnover3.694.63784.7845
Slightly volatile
Graham Number8.09.62211.3275
Slightly volatile
Capex Per Share0.340.31370.4317
Slightly volatile
Revenue Per Share9.4811.32314.3795
Slightly volatile
Interest Debt Per Share3.54.64935.7438
Very volatile
Debt To Assets0.30.34560.4116
Pretty Stable
Enterprise Value Over EBITDA13.7414.627320.699
Pretty Stable
Short Term Coverage Ratios6.466.811.8521
Slightly volatile
Operating Cycle129125114
Slightly volatile
Days Of Payables Outstanding33.2331.476729.2068
Pretty Stable
Price To Operating Cash Flows Ratio17.4220.050424.86
Very volatile
Price To Free Cash Flows Ratio34.6533.001133.9176
Slightly volatile
Ebt Per Ebit0.680.93950.8756
Slightly volatile
Long Term Debt To Capitalization0.380.35290.5633
Slightly volatile
Total Debt To Capitalization0.410.42450.5937
Pretty Stable
Quick Ratio2.161.56641.7057
Pretty Stable
Dividend Paid And Capex Coverage Ratio1.832.25882.1343
Pretty Stable
Net Income Per E B T0.540.69290.7722
Very volatile
Cash Ratio0.310.21320.1822
Very volatile
Cash Conversion Cycle95.5593.243385.1978
Slightly volatile
Operating Cash Flow Sales Ratio0.110.07060.1578
Slightly volatile
Days Of Inventory Outstanding28.0846.018936.4839
Slightly volatile
Days Of Sales Outstanding90.1778.701177.3013
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.480.60760.7537
Slightly volatile
Cash Flow Coverage Ratios0.170.18020.4656
Slightly volatile
Fixed Asset Turnover5.613.42364.9158
Slightly volatile
Capital Expenditure Coverage Ratio3.562.54825.4112
Slightly volatile
Price Cash Flow Ratio17.4220.050424.86
Very volatile
Enterprise Value Multiple13.7414.627320.699
Pretty Stable
Debt Ratio0.30.34560.4116
Pretty Stable
Cash Flow To Debt Ratio0.170.18020.4656
Slightly volatile
Price Sales Ratio2.61.41573.9559
Slightly volatile
Asset Turnover1.210.8821.132
Slightly volatile
Gross Profit Margin0.20.17910.2446
Slightly volatile

Core Laboratories Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap694.1 M730.6 M2.2 B
Slightly volatile
Enterprise Value831.7 M875.5 M2.4 B
Slightly volatile

Core Fundamental Market Drivers

Forward Price Earnings19.7628
Cash And Short Term Investments22.8 M

Core Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Core Laboratories Financial Statements

Core Laboratories stakeholders use historical fundamental indicators, such as Core Laboratories' revenue or net income, to determine how well the company is positioned to perform in the future. Although Core Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in Core Laboratories' assets and liabilities are reflected in the revenues and expenses on Core Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Core Laboratories NV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue10.7 M11.1 M
Total Revenue526.5 M616.6 M
Cost Of Revenue432.2 M448.9 M
Stock Based Compensation To Revenue 0.01  0.02 
Sales General And Administrative To Revenue 0.07  0.05 
Capex To Revenue 0.03  0.05 
Revenue Per Share 11.32  9.48 
Ebit Per Revenue 0.09  0.18 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out the analysis of Core Laboratories Correlation against competitors.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. Projected growth potential of Core fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Core Laboratories assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.03)
Dividend Share
0.04
Earnings Share
0.68
Revenue Per Share
11.196
Quarterly Revenue Growth
0.07
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Core Laboratories' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Core Laboratories should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Core Laboratories' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.